Australian Pharmaceutical Industries Ltd. Stock – Fundamental Analysis
Not enough price data available yet.
Fundamental Data & Ratios (Balance sheet update: 11/3/2021)
| Balance Sheet | Total Assets | 1,529,940,000.00 | ROE | – |
| Balance Sheet | Total Equity | 438,810,000.00 | ROA | – |
| Cashflow | Capital Expenditures | -45,854,000.00 | P/FCF | – |
| Cashflow | Free Cash Flow | 25,946,000.00 | – | – |
| Cashflow | Operating Cash Flow | 71,800,000.00 | P/CF | – |
| Income | Earnings per Share (diluted) | 0.00 | Div. Yield | – |
| Income | Net Income | 1,377,000.00 | P/E | – |
| Income | Shares Outstanding | 492,630,000.00 | P/B | – |
| Income | Total Revenue | 4,006,910,000.00 | P/S | – |
Ratios calculated on: –
Company Description
Australian Pharmaceutical Industries Limited engages in the wholesale distribution of pharmaceutical, medical, health, beauty, and lifestyle products to pharmacies. The company operates through two segments, Australia and New Zealand. It also provides wholesale product delivery, marketing programs, and business advisory services, as well as retail services to pharmacies. In addition, the company purchases and sells health, beauty, and lifestyle products within the retail industry; and manufactures and owns the rights of pharmaceutical medicines and consumer toiletries. It markets its products and services under the Soul Pattinson Chemist, Pharmacist Advice, Club Premium, and Pharmacy Best Buys brand names, as well as operates as a franchisor with 462 Priceline & Priceline Pharmacy stores. Australian Pharmaceutical Industries Limited was founded in 1910 and is based in Camberwell, Australia.
Additional comparison and history views are available after login.
Finanzoo GmbH assumes no liability for the accuracy of the information provided! All information is provided without guarantee. Sources: www.bundesanzeiger.de, www.sec.gov, www.api.net.au
All metrics and scores are an automated evaluation and not investment advice or a recommendation to buy or sell. Finanzoo GmbH or its shareholders may themselves hold positions in the securities shown.
Learn more